Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Fernandes, Laura L.
Kluetz, Paul G.
Text and Data Mining valid from 2021-08-01
Version of Record valid from 2021-08-31
7 June 2021
10 August 2021
17 August 2021
31 August 2021
All authors are employed at the U.S. FDA and have no conflicts of interest to disclose.